Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals 2023 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc (CPIX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 40,600 | $70,644 | +26% | 0% | |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 23,400 | $41,926 | -1% | 0% |
| 3. | 5,700 | $9,918 | -11% | 0% | |
| 4. | Citadel Investment Group Ken Griffin | 3,535 | $6,151 | -41% | 0% |
| 5. | Renaissance Technologies Jim Simons | 549,863 | $985,000 | -2% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.31 | 109 | Director | 19,587 | 2022-12-20 | Filing | |
| $2.21 | 30 | Director | 19,478 | 2022-12-19 | Filing | |
| $2.22 | 20 | Director | 19,448 | 2022-12-16 | Filing | |
| $2.24 | 20 | Director | 19,428 | 2022-12-15 | Filing | |
| $2.21 | 20 | Director | 19,408 | 2022-12-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.79 | 1,000 | Director | 0 | 2019-12-04 | Filing | |
| $5.31 | 3,470 | Director | 1,000 | 2019-09-25 | Filing | |
| $5.27 | 4,400 | Director | 4,470 | 2019-09-23 | Filing | |
| $5.31 | 3,700 | Director | 8,870 | 2019-09-20 | Filing | |
| $5.21 | 4,000 | Director | 12,170 | 2019-09-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 374,251 | $670,546 | 0% | |
| 2. | 365,934 | $636,725 | 0% | |
| 3. | 286,655 | $498,780 | 0.01% | |
| 4. | 110,990 | $198,860 | 0% | |
| 5. | 85,274 | $148,397 | 0% |
News See All
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals Third Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Cumberland Pharmaceuticals' Second Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals First Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals' 2022 Financial Report and Company Update.
Cumberland Pharmaceuticals, Inc. (CPIX): Are Hedge Funds Right About This Stock?
A whopping number of 13F filings filed with U.S.
Where Do Hedge Funds Stand On Cumberland Pharmaceuticals, Inc. (CPIX)?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
Is Cumberland Pharmaceuticals (CPIX) A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Cumberland Pharmaceuticals, Inc. (CPIX): Hedge Funds In Wait-and-See Mode
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second ...
13G Filing: Ariel Investments and Cumberland Pharmaceuticals Inc (CPIX)
You can access the original SEC filing by clicking here.
Billionaire Hedge Funds
